A novel immunoregulatory regimen combining high dose interleukin-2 and taurolidine for the treatment of patients with progressive metastatic melanoma

Verfasser / Beitragende:
[G. O'Brien, R. Cahill, M. O'Sullivan, D. Bouchier-Hayes, H. Redmond]
Ort, Verlag, Jahr:
2002
Enthalten in:
Irish Journal of Medical Science, 171(2002-01-01), 14-14
Format:
Artikel (online)
ID: 471117730